journal article·2024-10-11

Antimicrobial Efficacy of Cubic, Single-Leaf, and Flower-like Zeolitic Imidazolate Frameworks

Yanning Zhang, Shixin Cai, Xinzhang Li, Linpei Zhang, Menglu Li, Yuting Zhang, Xiaoli Wang, Nandi Zhou

ACS Applied Nano Materials· Volume 7· Issue 19
Publisher page

Abstract

Zeolite imidazolate frameworks (ZIFs) have been widely used in drug delivery and antibacterial applications due to their highly controllable structure and pore size. However, the relationship between the structure of ZIFs and their antibacterial efficacy has not been fully elucidated. In this study, three ZIFs with uniform sizes and specific morphologies were synthesized: cubic (Z-8), leaf-like (Z-L), and flower-like (FZ-L). Flow cytometry was employed to assess the effects of these materials on Bacillus subtilis and Escherichia coli at different concentrations and exposure times. Results showed that sharp-edged ZIFs possess enhanced antibacterial effects. Specifically, FZ-L exhibited the lowest minimum inhibitory concentration of 400 μg/mL and a minimum bactericidal concentration of 20 μg/mL, which can kill bacteria effectively and rapidly. Further study on the antibacterial mechanisms showed that these materials do not produce reactive oxygen species (ROS) themselves but induce ROS production in bacteria and accelerate bacterial death. Biocompatibility studies suggested that ZIFs have minimal toxicity to human cells, indicating their potential in biomedical applications. This research provides insights into the antibacterial mechanisms of ZIFs, which can support their development for antimicrobial use.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Medicinal Plants and Neuroprotection · Nanocomposite Films for Food Packaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biotechnology and Key Laboratory of Carbohydrate Chemistry and Biotechnology of Ministry of Education, Jiangnan University, Wuxi 214122, China

Department of Urology, Jiangnan University Medical Center (Wuxi No. 2 People’s Hospital), Wuxi 214000, China

Funding

National Key Research and Development Program of China · Wuxi Health and Family Planning Commission · National Natural Science Foundation of China

References (62)

Show source-provided references
1. 10.1016/j.talanta.2022.12383310.1016/j.talanta.2022.123833 ↗
2. 10.1016/j.bios.2024.11604610.1016/j.bios.2024.116046 ↗
3. 10.1021/acs.analchem.3c0568210.1021/acs.analchem.3c05682 ↗
4. 10.1016/j.biomaterials.2016.10.04110.1016/j.biomaterials.2016.10.041 ↗
5. 10.1016/j.bioactmat.2022.01.03610.1016/j.bioactmat.2022.01.036 ↗
6. 10.1021/acsanm.3c0506010.1021/acsanm.3c05060 ↗
7. 10.1021/acs.analchem.1c0128010.1021/acs.analchem.1c01280 ↗
8. 10.1002/anie.20221734510.1002/anie.202217345 ↗
9. 10.1021/acsami.2c1341510.1021/acsami.2c13415 ↗
10. 10.1016/j.snb.2021.13034510.1016/j.snb.2021.130345 ↗
11. 10.1007/s12274-020-3146-510.1007/s12274-020-3146-5 ↗
12. 10.1021/acsnano.7b0203510.1021/acsnano.7b02035 ↗
13. 10.1016/j.nantod.2023.10187510.1016/j.nantod.2023.101875 ↗
14. 10.1016/j.cclet.2022.06.07310.1016/j.cclet.2022.06.073 ↗
15. 10.1002/advs.20230715410.1002/advs.202307154 ↗
16. 10.1016/j.colcom.2018.08.00210.1016/j.colcom.2018.08.002 ↗
17. 10.1039/C8CY00078F10.1039/C8CY00078F ↗
18. 10.1016/j.jece.2022.10855810.1016/j.jece.2022.108558 ↗
19. 10.1039/C9NR03797G10.1039/C9NR03797G ↗
20. 10.1016/j.memsci.2019.11777310.1016/j.memsci.2019.117773 ↗
21. 10.1021/jacs.6b0024310.1021/jacs.6b00243 ↗
22. 10.1007/s40820-022-00826-410.1007/s40820-022-00826-4 ↗
23. 10.1021/acs.langmuir.8b0026210.1021/acs.langmuir.8b00262 ↗
24. 10.1038/s41467-020-15471-x10.1038/s41467-020-15471-x ↗
25. 10.1016/j.cis.2019.10206310.1016/j.cis.2019.102063 ↗
26. 10.1021/acsnano.8b0895910.1021/acsnano.8b08959 ↗
27. 10.1021/acsanm.4c0102910.1021/acsanm.4c01029 ↗
28. 10.1016/j.cclet.2024.10983510.1016/j.cclet.2024.109835 ↗
29. 10.1039/C7NR03739B10.1039/C7NR03739B ↗
30. 10.1021/acssuschemeng.1c0148810.1021/acssuschemeng.1c01488 ↗
31. 10.1016/j.apmt.2022.10143010.1016/j.apmt.2022.101430 ↗
32. 10.3390/cryst1304056410.3390/cryst13040564 ↗
33. 10.3389/fbioe.2022.102674310.3389/fbioe.2022.1026743 ↗
34. 10.1039/D4NA00142G10.1039/D4NA00142G ↗
35. 10.3390/ijms2314751010.3390/ijms23147510 ↗
36. 10.1039/C8NH00113H10.1039/C8NH00113H ↗
37. 10.1021/acsanm.2c0100310.1021/acsanm.2c01003 ↗
38. 10.1016/j.ecoenv.2020.11111010.1016/j.ecoenv.2020.111110 ↗
39. 10.1016/j.ica.2022.12111010.1016/j.ica.2022.121110 ↗
40. 10.1021/acsanm.3c0440010.1021/acsanm.3c04400 ↗
41. 10.1039/C9CE00833K10.1039/C9CE00833K ↗
42. 10.1039/C8TA10249J10.1039/C8TA10249J ↗
43. 10.1016/j.molliq.2017.12.00510.1016/j.molliq.2017.12.005 ↗
44. 10.1002/smll.20220568210.1002/smll.202205682 ↗
45. 10.1021/acsanm.4c0303410.1021/acsanm.4c03034 ↗
46. 10.1016/j.cej.2022.13679210.1016/j.cej.2022.136792 ↗
47. 10.1021/acsinfecdis.2c0049610.1021/acsinfecdis.2c00496 ↗
48. 10.1021/acsanm.3c0244310.1021/acsanm.3c02443 ↗
49. 10.1021/acsanm.4c0239310.1021/acsanm.4c02393 ↗
50. 10.1016/j.cej.2020.12751110.1016/j.cej.2020.127511 ↗
51. 10.1021/acs.analchem.3c0284110.1021/acs.analchem.3c02841 ↗
52. 10.1039/D0NR03809A10.1039/D0NR03809A ↗
53. 10.3390/nano1301020210.3390/nano13010202 ↗
54. 10.1039/D3NR05458F10.1039/D3NR05458F ↗
55. 10.1016/j.cej.2023.14320110.1016/j.cej.2023.143201 ↗
56. 10.1038/s41467-020-16544-710.1038/s41467-020-16544-7 ↗
57. 10.1021/acsnano.2c0959310.1021/acsnano.2c09593 ↗
58. 10.1021/acsami.8b0124510.1021/acsami.8b01245 ↗
59. 10.1016/j.actbio.2023.03.03010.1016/j.actbio.2023.03.030 ↗
60. 10.1021/acs.biomac.3c0106010.1021/acs.biomac.3c01060 ↗
61. 10.1002/advs.20230709410.1002/advs.202307094 ↗
62. 10.1002/smll.20230722010.1002/smll.202307220 ↗